Screener
Travere Therapeutics, Inc. TVTX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
FAQ
- What is Travere Therapeutics, Inc.'s invested capital?
- Travere Therapeutics, Inc. (TVTX) reported invested capital of $35.95M in Q1 2026.
- How has Travere Therapeutics, Inc.'s invested capital changed year-over-year?
- Travere Therapeutics, Inc.'s invested capital decreased by 40.8% year-over-year, from $60.73M to $35.95M.
- What is the long-term trend for Travere Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s invested capital has grown at a -24.8% compound annual growth rate (CAGR), from $160.94M to $38.8M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Travere Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude